Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/821
Full metadata record
DC FieldValueLanguage
dc.contributor.authorXodjimetova Iroda Xamidullaevna, Karimov Ma’rif Shakirovich-
dc.date.accessioned2024-12-28T04:04:09Z-
dc.date.available2024-12-28T04:04:09Z-
dc.date.issued2024-12-27-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/821-
dc.description.abstractThis study focused on evaluating the role of matrix metalloproteinase 9 (MMP-9) in the progression of rheumatoid arthritis (RA) and its potential impact on liver function. Sixty patients, split into a main group and a control group, wore analysed through a combination of clinical, laboratory, and imaging assessments. Elevated MMP-9 levels were found to be associated with more severe disease progression, including higher rates of hypertension, stroke, and ischaemic heart disease in the main group. These findings suggest that MMP-9 could serve as a valuable biomarkcr for predicting RA severity and liver pathology. The study recommends early detection and continuous monitoring of MMP-9 to guide treatment strategics. Future research should further investigate MMP-9’s role in RA-rclated liver dysfunction and explore the development of therapies aimed at modulating MMP-9 levels to improve patient outcomes.en_US
dc.language.isoen_USen_US
dc.subjectrheumatoid arthritis, matrix metalloproteinases.en_US
dc.title"SIGNIFICANCE OF EXTRACELLULAR BIOCHEMICAL MARKERS IN RHEUMATOID ARTHRITIS AND THEIR IMPACT ON LIVER FUNCTION"en_US
dc.title.alternative"Patient-Centered Approaches to Medical Intervention Proceedings of International Conference September 27 & 28, 2024 I Online I Worldwide"en_US
dc.typeArticleen_US
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
Ходжиметова И.Х., Каримов М.Ш..pdf1.87 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.